Stay updated on Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial
Sign up to get notified when there's something new on the Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial page.

Latest updates to the Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision v3.5.0 has been added. Revision v3.4.3 has been removed.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedPage revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check48 days agoChange DetectedAdded 'Gastric cancer' as a condition/topic and included a resources entry for Genetic and Rare Diseases Information Center related to gastric cancer.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page shows an administrative Revision: v3.4.2 and removal of a general funding/status notice (including Revision: v3.4.1), which do not affect the study content or results; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedAdded a government funding lapse notice and updated the site to revision v3.4.1 (with v3.4.0 removed). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check69 days agoChange DetectedGlossary visibility has been enabled on the page. The update history metadata now shows 'Last Update Submitted that Met QC Criteria' and the revision tag has been updated to v3.4.0.SummaryDifference0.2%

Stay in the know with updates to Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial page.